Cardiolipin deficiency disrupts electron transport chain to drive steatohepatitis
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health concern with an increasing prevalence that parallels the rise in obesity.1 In the United States, annual medical costs related to MASLD exceed $103 billion.2 A large …